Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.
After liver transplantation there is a high incidence of fractures, with important rates of bone loss during the first months. However, the long-term evolution of bone mass and metabolism parameters have been scarcely studied. In order to determine the incidence and risk factors involved in the development of skeletal fractures and to analyze the long-term evolution of bone mass, bone turnover and hormonal status after liver transplantation, a 3-year prospective study was performed in 45 patients following liver transplantation. Serum osteocalcin, parathyroid hormone (PTH), 25-hydroxyvitamin D (25-OH D) and testosterone levels (men), and bone mass at the lumbar spine and femur were measured before and sequentially at different time points during 3 years. Spinal X-rays were obtained during the first year. Histomorphometric analysis of bone biopsies obtained in 24 patients within the first 12 hours after surgery and 6 months after transplantation was performed. Fifteen patients (33%) developed fractures after liver transplantation, and pre-transplant risk factors for fractures were age and low bone mass (odd's ratio for osteoporosis, 95% confidence interval: 5.69, 1.32-24.53). Serum PTH, osteocalcin, 25-OH D, testosterone and creatinine levels increased after transplantation. Moreover, PTH correlated with creatinine and osteocalcin values. Bone mass decreased during the first 6 months and reached baseline values at the lumbar spine the second year, with posterior significant recovery at the femoral neck. Long term evolution of femoral neck BMD correlated with PTH levels. Six months after transplantation bone histomorphometric data showed an increase in bone formation parameters. After liver transplantation there is a high incidence of fractures, specially in elderly patients and those with osteoporosis. Bone mass decreased in the short-term period and improved, initially at the lumbar spine and later at the femur, according to histomorphometric evidences of an increase in bone formation. The increase in creatinine values induces a secondary hyperparathyroidism that influences the changes in femoral bone mass. Treatment of osteoporosis shortly after liver transplantation may be important in the prevention of bone fractures, particularly in patients with low bone mass.
Monegal
A
A
Department of Rheumatology, Hospital Clinic, IDIBAPS, University of Barcelona, Spain. 21607amb@comb.es
Navasa
M
M
Guañabens
N
N
Peris
P
P
Pons
F
F
Martinez de Osaba
M J
MJ
Ordi
J
J
Rimola
A
A
Rodés
J
J
Muñoz-Gómez
J
J
D000328:Adult; D015519:Bone Density; D001847:Bone Diseases / Q000209:etiology*; D016723:Bone Remodeling / Q000187:drug effects; D005260:Female; D005272:Femur Neck; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000502:physiology; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood; D011446:Prospective Studies; D012738:Sex Hormone-Binding Globulin; D013739:Testosterone / Q000097:blood; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
D008903:Minerals; D010281:Parathyroid Hormone; D012738:Sex Hormone-Binding Globulin; D015675:Osteocalcin; D014807:Vitamin D; D013739:Testosterone; C104450:25-hydroxyvitamin D